| PAHC |
PHIBRO ANIMAL HEALTH CORP |
BFI Co., LLC |
10% Owner
|
2026-01-26 |
C - D |
30,000 |
0.00 |
0.00 |
19,911,034 |
| PED |
PEDEVCO CORP |
PINKSTON PAUL ANTHONY |
|
2026-01-26 |
F - D |
24,709 |
0.59 |
14,652.44 |
753,224 |
| PSMT |
PRICESMART INC |
PRICE ROBERT E |
|
2026-01-26 |
S - D |
2,000 |
141.27 |
282,541.00 |
43,000 |
| PSMT |
PRICESMART INC |
PRICE ROBERT E |
|
2026-01-26 |
S - D |
2,000 |
141.27 |
282,541.00 |
43,000 |
| BKTI |
BK Technologies Corp |
Payne E. Gray |
Director
|
2026-01-26 |
A - A |
461 |
0.00 |
0.00 |
32,252 |
| MIRM |
Mirum Pharmaceuticals, Inc. |
Peetz Christopher |
|
2026-01-26 |
S - D |
6,831 |
96.19 |
657,087.55 |
169,402 |
| EXPI |
eXp World Holdings, Inc. |
Pelosi Peggie |
|
2026-01-26 |
A - A |
5,258 |
0.00 |
0.00 |
5,258 |
| ADBE |
ADOBE INC. |
Pentland Adele Louise |
Officer
|
2026-01-26 |
A - A |
20,933 |
0.00 |
0.00 |
20,933 |
| HPI |
JOHN HANCOCK PREFERRED INCOME FUND |
Phelan Kenneth J |
Director
|
2026-01-26 |
P - A |
614 |
16.30 |
10,001.00 |
614 |
| HPF |
JOHN HANCOCK PREFERRED INCOME FUND II |
Phelan Kenneth J |
Director
|
2026-01-26 |
P - A |
618 |
16.18 |
10,000.99 |
618 |
| HPS |
JOHN HANCOCK PREFERRED INCOME FUND III |
Phelan Kenneth J |
Director
|
2026-01-26 |
P - A |
683 |
14.65 |
10,001.00 |
683 |
| JHS |
JOHN HANCOCK INCOME SECURITIES TRUST |
Phelan Kenneth J |
Director
|
2026-01-26 |
P - A |
130 |
11.75 |
1,527.50 |
130 |
| PDT |
JOHN HANCOCK PREMIUM DIVIDEND FUND |
Phelan Kenneth J |
Director
|
2026-01-26 |
P - A |
774 |
12.92 |
10,001.00 |
774 |
| HTD |
JOHN HANCOCK TAX-ADVANTAGED DIVIDEND INCOME FUND |
Phelan Kenneth J |
Director
|
2026-01-26 |
P - A |
415 |
24.09 |
10,000.99 |
415 |
| BTO |
JOHN HANCOCK FINANCIAL OPPORTUNITIES FUND |
Phelan Kenneth J |
Director
|
2026-01-26 |
P - A |
270 |
37.10 |
10,001.01 |
270 |
| PTGX |
Protagonist Therapeutics, Inc |
MOLINA ARTURO MD |
Officer
|
2026-01-26 |
M - A |
5,000 |
8.04 |
40,200.00 |
89,115 |
| PTGX |
Protagonist Therapeutics, Inc |
MOLINA ARTURO MD |
Officer
|
2026-01-26 |
S - D |
5,000 |
82.28 |
411,400.00 |
84,115 |
| PTGX |
Protagonist Therapeutics, Inc |
MOLINA ARTURO MD |
Officer
|
2026-01-26 |
M - D |
5,000 |
0.00 |
0.00 |
70,971 |
| PTGX |
Protagonist Therapeutics, Inc |
PATEL DINESH V PH D |
Director
Officer
|
2026-01-26 |
M - A |
10,685 |
4.21 |
44,983.85 |
585,190 |
| PTGX |
Protagonist Therapeutics, Inc |
PATEL DINESH V PH D |
Director
Officer
|
2026-01-26 |
S - D |
10,685 |
84.00 |
897,540.00 |
574,505 |
| PTGX |
Protagonist Therapeutics, Inc |
PATEL DINESH V PH D |
Director
Officer
|
2026-01-26 |
M - A |
14,205 |
21.58 |
306,543.90 |
588,710 |
| PTGX |
Protagonist Therapeutics, Inc |
PATEL DINESH V PH D |
Director
Officer
|
2026-01-26 |
S - D |
14,205 |
84.05 |
1,193,930.25 |
574,505 |
| PTGX |
Protagonist Therapeutics, Inc |
PATEL DINESH V PH D |
Director
Officer
|
2026-01-26 |
M - D |
10,685 |
0.00 |
0.00 |
0 |
| PTGX |
Protagonist Therapeutics, Inc |
PATEL DINESH V PH D |
Director
Officer
|
2026-01-26 |
M - D |
14,205 |
0.00 |
0.00 |
304,068 |
| TARA |
Protara Therapeutics, Inc. |
Fabbio Patrick |
|
2026-01-26 |
F - D |
3,261 |
6.67 |
21,750.87 |
64,115 |